Linder A, Venge P, Deuschl H
Dept. of Otolaryngology, Akademiska Sjukhuset, Uppsala, Sweden.
Allergy. 1987 Nov;42(8):583-90. doi: 10.1111/j.1398-9995.1987.tb00388.x.
The inflammatory component of allergic rhinitis was studied by measuring the concentration and content of eosinophil cationic protein (ECP, specific for eosinophils) and myeloperoxidase (MPO, specific for neutrophils) in samples of nasal secretion from 20 pollen-allergic subjects. All secretion samples contained measurable concentrations of both proteins. The mean ECP concentrations on two occasions without pollen exposure were 950 and 1170 micrograms/l. The ECP concentration during the pollen season without any therapy (mean 1160 micrograms/l) did not differ significantly from the baseline values, but intranasal corticosteroid therapy resulted in a significant decrease (mean 530 micrograms/l). The concentration of MPO was about 10 times higher than that of ECP, but the changes in MPO were nonsignificant throughout the observation period. An inverse correlation was found between the threshold dose in histamine challenges and the ECP level expressed either as concentration or as content. Furthermore, the ECP concentration and content 1 day after a positive allergen challenge were both significantly correlated with the strength of the challenge reaction. Measurements of ECP in nasal secretions are useful for studying the presence and activity of eosinophils in the nasal mucosa, and may prove of value in clinical investigations on patients with allergic rhinitis.
通过检测20名花粉过敏受试者鼻分泌物样本中嗜酸性粒细胞阳离子蛋白(ECP,嗜酸性粒细胞特异性蛋白)和髓过氧化物酶(MPO,中性粒细胞特异性蛋白)的浓度和含量,对过敏性鼻炎的炎症成分进行了研究。所有分泌物样本中这两种蛋白的浓度均可测。在未接触花粉的两个时间点,ECP平均浓度分别为950和1170微克/升。在花粉季节未经任何治疗时的ECP浓度(平均1160微克/升)与基线值无显著差异,但鼻内使用皮质类固醇治疗后显著降低(平均530微克/升)。MPO的浓度比ECP高约10倍,但在整个观察期内MPO的变化不显著。在组胺激发试验中的阈值剂量与以浓度或含量表示的ECP水平之间存在负相关。此外,阳性变应原激发试验后1天的ECP浓度和含量均与激发反应的强度显著相关。检测鼻分泌物中的ECP有助于研究鼻黏膜中嗜酸性粒细胞的存在和活性,可能对过敏性鼻炎患者的临床研究具有价值。